WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sees Large Volume Increase – Here’s What Happened

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw an uptick in trading volume on Wednesday. 130,387 shares traded hands during trading, an increase of 82% from the previous session’s volume of 71,527 shares. The stock last traded at $13.7380 and had previously closed at $13.78.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Down 0.5%

The business’s fifty day moving average is $11.73 and its 200-day moving average is $9.74.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.